J&J to Acquire Aragon Pharmaceuticals for Close to $1B
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens...
-
Business
Featured Story
-
Marketing & Advertising
Featured Story
BMS in Orencia Deal With China's Simcere
The companies have expanded their strategic relationship formed in 2010
-
R&D
Featured Story
BMS, AbbVie: PFS in Phase II Elotuzumab Study
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in...
-
Therapeutics
Featured Story
Novartis: Jakavi Improved Overall Survival of Myelofibrosis Patients
Novartis drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease Jakavi® reduced risk of...
-
Pharmalot
Featured Story
Supreme Court Rules Drugmakers Can Be Sued For Pay-To-Delay Deals
After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over so-called pay-to-delay...
- Resources
- Directories
- Manny Awards
- Events
- Jobs
